Mk0476 [montelukast] phase II dose finding study -allergic rhinitis-
Latest Information Update: 05 May 2022
At a glance
- Drugs Montelukast (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 02 May 2007 New trial record.